AI & Machine Learning– category –
-
AI-Based Early Cardiovascular Disease Diagnosis System Shows Promising Detection Rate Improvement in Phase 2 Clinical Trial (Hypothetical Article)
ClinicalTrials.gov USA Overview An interim report from an ongoing Phase 2 clinical trial on an AI-based system for early cardiovascular disease diagnosis indicates promising improvements in detection rates among high-risk patients compar... -
Meta AI Introduces ‘Muse Spark 1.1’ Multimodal Reasoning Model with Major Enhancements in Tool Use, Coding, and Multi-Agent Orchestration
Meta AI USA Overview Meta AI has unveiled Muse Spark 1.1, a new multimodal reasoning model designed for agentic tasks, demonstrating significant improvements in tool and computer use, coding, and multimodal understanding. Capable of mana... -
Oracle Significantly Enhances AI Agent Memory with Custom Extraction, Hybrid Search, and Advanced Enterprise Control
Oracle USA Overview Oracle has substantially upgraded its AI Agent Memory, backed by Oracle AI Database, providing developers with enhanced control over context retention and retrieval. New features include custom extraction instructions... -
ISSCR 2026: Fate Therapeutics’ FT819 iPSC-Derived CAR T-Cell Therapy Shows Favorable Tolerability and Promising Clinical Activity in Systemic Sclerosis Phase 1 Trial
International Society for Stem Cell Research (ISSCR) International Overview The ISSCR 2026 Annual Meeting presented updated clinical data on multiple stem cell therapies, highlighting Fate Therapeutics' FT819, an iPSC-derived CAR T-cell ... -
High-Quality Patient Data is Key to AI’s Clinical Trial Transformation: Deepening Gene Expression and Molecular Pathway Analysis
Clinical Leader USA Overview A Clinical Leader article asserts that more high-quality patient data is essential for AI to truly transform clinical trials. New technologies now generate rich, unbiased data on gene expression, protein acti... -
Harvard Medical School’s ‘COMPASS’ AI Model Achieves 8.5% Higher Accuracy in Predicting Cancer Immunotherapy Response
Harvard Medical School USA Overview Harvard Medical School researchers developed 'COMPASS,' an AI model that predicts patient response to cancer immunotherapy drugs, published July 3 in Nature Medicine. COMPASS achieved 8.5% higher accur... -
AI Achieves Over 80% Diagnostic Accuracy in Oncology, Revolutionizing Surgical Precision, Drug/Biomarker Screening, and Clinical Trial Design
OncLive USA Overview AI tools are increasingly integrated into oncology, enhancing surgical precision, diagnostic accuracy, biomarker-driven treatment selection, and streamlining clinical trial enrollment. A meta-analysis cited a narrati... -
Weill Cornell Medicine Unveils ‘EmulatRx’ AI System to Accelerate and Enhance Clinical Trial Design with Real-World Data
Cornell Chronicle / Weill Cornell Medicine USA Overview Weill Cornell Medicine researchers have developed EmulatRx, an AI system designed to accelerate clinical trial design by leveraging real-world patient data (RWD). Published in Natur... -
July 2026 AI Trends: Shift from Large Models to Practicality, Cost-Efficiency, Multimodal AI, and Autonomous Agents Emerge
ZoneTechify Blog USA Overview July 2026 AI trends show a significant pivot from larger models to practical, cost-efficient, and reliable AI solutions, with inference costs plummeting. Multimodal models, capable of processing text, image,... -
Aureka Launches Open-Source AI Foundation Model ‘OpenDDE’ for Drug Discovery, Enhancing Structure Prediction and Antibody Modeling
pharmaphorum USA Overview Aureka, a US and China-based techbio company, has released Open Drug Discovery Engine (OpenDDE), an open-source AI foundation model for drug discovery. OpenDDE serves as the structural reasoning core for next-ge...
